Association of Metabolic Dysregulation With Volumetric Brain Magnetic Resonance Imaging and Cognitive Markers of Subclinical Brain Aging in Middle-Aged Adults

OBJECTIVE Diabetic and prediabtic states, including insulin resistance, fasting hyperglycemia, and hyperinsulinemia, are associated with metabolic dysregulation. These components have been individually linked to increased risks of cognitive decline and Alzheimer’s disease. We aimed to comprehensively relate all of the components of metabolic dysregulation to cognitive function and brain magnetic resonance imaging (MRI) in middle-aged adults. RESEARCH DESIGN AND METHODS Framingham Offspring participants who underwent volumetric MRI and detailed cognitive testing and were free of clinical stroke and dementia during examination 7 (1998–2001) constituted our study sample (n = 2,439; 1,311 women; age 61 ± 9 years). We related diabetes, homeostasis model assessment of insulin resistance (HOMA-IR), fasting insulin, and glycohemoglobin levels to cross-sectional MRI measures of total cerebral brain volume (TCBV) and hippocampal volume and to verbal and visuospatial memory and executive function. We serially adjusted for age, sex, and education alone (model A), additionally for other vascular risk factors (model B), and finally, with the inclusion of apolipoprotein E-ε4, plasma homocysteine, C-reactive protein, and interleukin-6 (model C). RESULTS We observed an inverse association between all indices of metabolic dysfunction and TCBV in all models (P < 0.030). The observed difference in TCBV between participants with and without diabetes was equivalent to approximately 6 years of chronologic aging. Diabetes and elevated glycohemoglobin, HOMA-IR, and fasting insulin were related to poorer executive function scores (P < 0.038), whereas only HOMA-IR and fasting insulin were inversely related to visuospatial memory (P < 0.007). CONCLUSIONS Metabolic dysregulation, especially insulin resistance, was associated with lower brain volumes and executive function in a large, relatively healthy, middle-aged, community-based cohort.

[1]  R. D'Agostino,et al.  New Norms for a New Generation: Cognitive Performance in the Framingham Offspring Cohort , 2004, Experimental aging research.

[2]  Charles DeCarli,et al.  Stroke Risk Profile Predicts White Matter Hyperintensity Volume: The Framingham Study , 2004, Stroke.

[3]  Ha T. Nguyen,et al.  Linking Glycemic Control and Executive Function in Rural Older Adults with Diabetes Mellitus , 2010, Journal of the American Geriatrics Society.

[4]  Claude Messier,et al.  The Relationship between Impaired Glucose Tolerance, Type 2 Diabetes, and Cognitive Function , 2004, Journal of clinical and experimental neuropsychology.

[5]  PSYCHOLOGIC TESTS APPLIED TO DIABETIC PATIENTS , 1922 .

[6]  R. Little.  Glycated Hemoglobin Standardization – National Glycohemoglobin Standardization Program (NGSP) Perspective , 2003, Clinical chemistry and laboratory medicine.

[7]  R B D'Agostino,et al.  Stroke risk profile, brain volume, and cognitive function , 2004, Neurology.

[8]  E. Barrett-Connor,et al.  Diabetes, impaired fasting glucose, and development of cognitive impairment in older women , 2004, Neurology.

[9]  C. DeCarli,et al.  Association of parental dementia with cognitive and brain MRI measures in middle-aged adults , 2009, Neurology.

[10]  P. Scheltens,et al.  Risk of dementia in diabetes mellitus: a systematic review , 2006, The Lancet Neurology.

[11]  Suzanne Craft,et al.  The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. , 2009, Archives of neurology.

[12]  D. Bennett,et al.  Diabetes is related to cerebral infarction but not to AD pathology in older persons , 2006, Neurology.

[13]  Michael E. Miller,et al.  Relationship Between Baseline Glycemic Control and Cognitive Function in Individuals With Type 2 Diabetes and Other Cardiovascular Risk Factors , 2009, Diabetes Care.

[14]  G. Paolisso,et al.  Relationship Between Baseline Glycemic Control and Cognitive Function in Individuals With Type 2 Diabetes and Other Cardiovascular Risk Factors: The Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Trial , 2009, Diabetes Care.

[15]  G. Schellenberg,et al.  Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. , 2008, Journal of Alzheimer's disease : JAD.

[16]  P. J. Koudstaal,et al.  Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI , 2003, Diabetologia.

[17]  G. Winocur,et al.  Cognitive performance is associated with glucose regulation in healthy elderly persons and can be enhanced with glucose and dietary carbohydrates. , 2000, The American journal of clinical nutrition.

[18]  J. Barrett,et al.  Differential Effects of Insulin on Choline Acetyltransferase and Glutamic Acid Decarboxylase Activities in Neuron‐Rich Striatal Cultures , 1992, Journal of neurochemistry.

[19]  R. Mayeux,et al.  Hyperinsulinemia and risk of Alzheimer disease , 2004, Neurology.

[20]  B. Horwitz,et al.  Method for quantification of brain, ventricular, and subarachnoid CSF volumes from MR images. , 1992, Journal of computer assisted tomography.

[21]  Roberta F. White,et al.  The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. , 2000, Archives of neurology.

[22]  P. Wolf,et al.  The lifetime risk of stroke: estimates from the Framingham Study. , 2006, Stroke.

[23]  D. Bennett,et al.  Alzheimer disease in the US population: prevalence estimates using the 2000 census. , 2003, Archives of neurology.

[24]  M. Laakso,et al.  Cognitive Function in an Elderly Population With Persistent Impaired Glucose Tolerance , 1998, Diabetes Care.

[25]  S. Minoshima,et al.  Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. , 2011, Archives of neurology.